Clare Y. Slaney

3.7k total citations
38 papers, 2.6k citations indexed

About

Clare Y. Slaney is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Clare Y. Slaney has authored 38 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 26 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Clare Y. Slaney's work include CAR-T cell therapy research (21 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (14 papers). Clare Y. Slaney is often cited by papers focused on CAR-T cell therapy research (21 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (14 papers). Clare Y. Slaney collaborates with scholars based in Australia, United States and New Zealand. Clare Y. Slaney's co-authors include Phillip K. Darcy, Michael H. Kershaw, Belinda S. Parker, Paul A. Beavis, Sherene Loi, Bradley N. Bidwell, Robin L. Anderson, Pin Wang, Amanda J. Oliver and Jack D. Chan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Clare Y. Slaney

37 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clare Y. Slaney Australia	23	1.8k	1.2k	761	434	304	38	2.6k
Tori N. Yamamoto United States	17	1.4k 0.8×	1.2k 1.0×	875 1.1×	365 0.8×	308 1.0×	21	2.5k
Stefanie R. Bailey United States	19	1.6k 0.9×	1.1k 0.9×	699 0.9×	468 1.1×	383 1.3×	35	2.3k
Liza B. John Australia	16	1.7k 0.9×	1.2k 1.0×	612 0.8×	389 0.9×	399 1.3×	27	2.4k
Kheng Newick United States	14	1.9k 1.0×	897 0.7×	819 1.1×	608 1.4×	445 1.5×	15	2.4k
Christel Devaud Australia	16	1.4k 0.7×	1.0k 0.8×	441 0.6×	292 0.7×	322 1.1×	27	1.9k
Keichiro Mihara Japan	21	1.2k 0.6×	645 0.5×	914 1.2×	278 0.6×	340 1.1×	70	2.4k
Whitney L. Gladney United States	14	1.8k 1.0×	1.2k 1.0×	584 0.8×	415 1.0×	261 0.9×	24	2.4k
Steven L. Highfill United States	23	1.6k 0.9×	1.7k 1.4×	719 0.9×	321 0.7×	348 1.1×	86	2.9k
Michael P. Rettig United States	27	1.4k 0.7×	1.1k 0.9×	977 1.3×	170 0.4×	257 0.8×	122	3.5k
Evripidis Lanitis Switzerland	19	1.6k 0.9×	887 0.7×	695 0.9×	562 1.3×	367 1.2×	25	2.2k

Countries citing papers authored by Clare Y. Slaney

Since Specialization

Citations

This map shows the geographic impact of Clare Y. Slaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Y. Slaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Y. Slaney more than expected).

Fields of papers citing papers by Clare Y. Slaney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Y. Slaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Y. Slaney. The network helps show where Clare Y. Slaney may publish in the future.

Co-authorship network of co-authors of Clare Y. Slaney

This figure shows the co-authorship network connecting the top 25 collaborators of Clare Y. Slaney. A scholar is included among the top collaborators of Clare Y. Slaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare Y. Slaney. Clare Y. Slaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Du, Xin, Pei Kee Goh, Chenkai Ma, et al.. (2025). Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models. Science Translational Medicine. 17(822). eadk0627–eadk0627.

Jenkins, Misty R., Michael H. Kershaw, Anthony Jaworowski, et al.. (2024). Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals. Clinical & Translational Immunology. 13(12). e70016–e70016. 1 indexed citations

Bai, Yuchen, Carolin Götz, Zixuan Zhao, et al.. (2023). YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells. Nature Communications. 14(1). 1591–1591. 19 indexed citations

Chan, Jack D., Junyun Lai, Clare Y. Slaney, et al.. (2021). Cellular networks controlling T cell persistence in adoptive cell therapy. Nature reviews. Immunology. 21(12). 769–784. 155 indexed citations

Du, Xin, et al.. (2021). Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers. PubMed. 1(1). ltab016–ltab016. 15 indexed citations

Lau, Peter K. H., Carleen Cullinane, Susan Jackson, et al.. (2021). Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma. Cancers. 13(24). 6342–6342. 6 indexed citations

Chan, Jack D., Bianca von Scheidt, Bijun Zeng, et al.. (2020). Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells. Clinical & Translational Immunology. 9(7). e1157–e1157. 26 indexed citations

Oliver, Amanda J., Phillip K. Darcy, Joseph A. Trapani, Michael H. Kershaw, & Clare Y. Slaney. (2020). Cross‐talk between tumors at anatomically distinct sites. FEBS Journal. 288(1). 81–90. 8 indexed citations

Audenaerde, Jonas R.M. Van, Elly Marcq, Bianca von Scheidt, et al.. (2020). Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment. Clinical & Translational Immunology. 9(8). e1165–e1165. 28 indexed citations

10.

Scheidt, Bianca von, Minyu Wang, Amanda J. Oliver, et al.. (2019). Enterotoxins can support CAR T cells against solid tumors. Proceedings of the National Academy of Sciences. 116(50). 25229–25235. 16 indexed citations

11.

Beavis, Paul A., Melissa A. Henderson, Lauren Giuffrida, et al.. (2018). Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells. Cancer Immunology Research. 6(9). 1069–1081. 51 indexed citations

12.

Oliver, Amanda J., Peter K. H. Lau, Sherene Loi, et al.. (2018). Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses. Frontiers in Immunology. 9. 70–70. 118 indexed citations

13.

Mardiana, Sherly, Liza B. John, Melissa A. Henderson, et al.. (2017). A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells. Cancer Research. 77(6). 1296–1309. 63 indexed citations

14.

Beavis, Paul A., Melissa A. Henderson, Lauren Giuffrida, et al.. (2017). Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy. Journal of Clinical Investigation. 127(3). 929–941. 259 indexed citations

15.

Slaney, Clare Y., Bianca von Scheidt, Alexander J. Davenport, et al.. (2016). Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting. Clinical Cancer Research. 23(10). 2478–2490. 89 indexed citations

16.

Rautela, Jai, Nikola Baschuk, Clare Y. Slaney, et al.. (2015). Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer. Cancer Immunology Research. 3(11). 1207–1217. 60 indexed citations

17.

Duong, Connie P.M., Carmen S. Yong, Michael H. Kershaw, Clare Y. Slaney, & Phillip K. Darcy. (2015). Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic. Molecular Immunology. 67(2). 46–57. 82 indexed citations

18.

Cao, Yuan, Clare Y. Slaney, Bradley N. Bidwell, et al.. (2014). BMP4 Inhibits Breast Cancer Metastasis by Blocking Myeloid-Derived Suppressor Cell Activity. Cancer Research. 74(18). 5091–5102. 99 indexed citations

19.

Slaney, Clare Y., Aras Toker, John D. Fraser, Jacquie L. Harper, & B. Thomas Bäckström. (2013). A modified superantigen rescues Ly6G⁻CD11b⁺blood monocyte suppressor function and suppresses antigen-specific inflammation in EAE. Autoimmunity. 46(4). 269–278. 4 indexed citations

20.

Withana, Nimali P., Galia Blum, Mansoureh Sameni, et al.. (2012). Cathepsin B Inhibition Limits Bone Metastasis in Breast Cancer. Cancer Research. 72(5). 1199–1209. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact